Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in ...

Many novel drugs are more relevant for subspecialists, but of the six first-in-class medications approved by the US Food and ...

Objective: To review drug interaction studies of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and concurrent oral medications. Data Sources: PubMed was searched (to December 5, 2011 ...

A new international study reveals a possible connection between GLP1 receptor agonists—used in drugs like Ozempic—and ...

A once-daily weight loss pill that mimics the effects of popular injectable drugs like Ozempic and Wegovy could soon hit the market. Eli Lilly’s experimental oral medication, orforglipron, has shown ...

A team of scientists has uncovered the mechanism of cellular uptake for large and polar drugs and devised a novel strategy to ...

Stimulating a receptor in adipocytes enhanced energy expenditure and caused sustained weight loss in mice, offering targets ...

Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in common that they are triggered by an excessive immune response -- which in ...

One exciting area of research involves finding drugs that mimic the effects of caloric restriction. Some of the most ...

UF scientists have developed a compound that safely activates delta opioid receptors, offering pain relief without ...

Discover the effectiveness and safety of Mounjaro, the new weight loss drug launched in India. Learn from expert Dr. Pal ...

If we can develop drugs that safely target the delta receptor, we might achieve effective pain relief without the lethal concerns." The need for safer pain treatments is urgent.